國際永勝集團(08441.HK)公開發售超購約41.56倍 預期10月22日上市
格隆匯10月21日丨國際永勝集團(08441.HK)公佈,發售2億股,其中香港發售6000萬股,配售1.4億股;發售價每股0.32港元;每手10,000股;預期10月22日上市。
公告顯示,香港公開發售獲大幅超額認購,相當於香港公開發售項下初步可供認購香港發售股份約41.56倍。
配售獲輕微超額認購,配售項下的最終發售股份數目為1.4億股股份,相當於股份發售項下初步可供認購發售股份的70%。
公告稱,所得款項淨額3200萬港元。其中,約45.3%用於(i)提供合約抵押;(ii)聘請保安服務人員;及(iii)購買巡邏車以承接新合約;約13.4%用於擴充營運團隊及銷售與營銷團隊;及(ii)購買機器及設備;約15.5%用於(i)在香港設立控制室;及(ii)進行資訊科技基礎設施升級;約15.8%用於償還部分銀行借款;約10.0%用於一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.